Caberlotto L, Rimondini R, Hansson A, Eriksson S, Heilig M (2004) Corticotropin-releasing hormone (CRH) mRNA expression in rat central amygdala in cannabinoid tolerance and withdrawal: evidence for an allostatic shift? Neuropsychopharmacology 29: 15-22

Cabral GA, Harmon KN, Carlisle SJ (2001) Cannabinoid-mediated inhibition of inducible nitric oxide production by rat microglial cells: evidence for CB1 receptor participation. Adv Exp Med Biol 493: 207-214

Cabral GA, Toney DM, Fischer-Stenger K, Harrison MP, Marciano-Cabral F (1995) Anandamide inhibits macrophage-mediated killing of tumor necrosis factor-sensitive cells. Life Sci 56: 2065-2072

Cadas H, di Tomaso E, Piomelli D (1997) Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. J Neurosci 17: 1226-1242

Cadas H, Gaillet S, Beltramo M, Venance L, Piomelli D (1996) Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP. J Neurosci 16: 3934-3942

Cadas H, Schinelli S, Piomelli D (1996) Membrane localization of N-acylphosphatidylethanolamine in central neurons: studies with exogenous phospholipases. J Lipid Mediat Cell Signal 14: 63-70

Cadogan AK, Alexander SP, Boyd EA, Kendall DA (1997) Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum. J Neurochem 69: 1131-1137

Caille S, Parsons LH (2003) SR141716A reduces the reinforcing properties of heroin but not heroin-induced increases in nucleus accumbens dopamine in rats. Eur J Neurosci 18: 3145-3149

Cainazzo MM, Ferrazza G, Mioni C, Bazzani C, Bertolini A, Guarini S (2002) Cannabinoid CB(1) receptor blockade enhances the protective effect of melanocortins in hemorrhagic shock in the rat. Eur J Pharmacol 441: 91-97

Cajal Y, Jain MK (1997) Synergism between mellitin and phospholipase A2 from bee venom: apparent activation by intervesicle exchange of phospholipids. Biochemistry 36: 3882-3893

Calandra B, Portier M, Kerneis A, Delpech M, Carillon C, Le Fur G, Ferrara P, Shire D (1999) Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor. Eur J Pharmacol 374: 445-455

Caldwell MA, Svendsen CN (1998) Heparin, but not other proteoglycans potentiates the mitogenic effects of FGF-2 on mesencephalic precursor cells. Exp Neurol 152: 1-10

Calignano A, Katona I, Desarnaud F, Giuffrida A, La Rana G, Mackie K, Freund TF, Piomelli D (2000) Bidirectional control of airway responsiveness by endogenous cannabinoids. Nature 408: 96-101

Calignano A, La Rana G, Beltramo M, Makriyannis A, Piomelli D (1997) Potentiation of anandamide hypotension by the transport inhibitor, AM404. Eur J Pharmacol 337: R1-2

Calignano A, La Rana G, Giuffrida A, Piomelli D (1998) Control of pain initiation by endogenous cannabinoids. Nature 394: 277-281

Calignano A, La Rana G, Loubet-Lescoulie P, Piomelli D (2000) A role for the endogenous cannabinoid system in the peripheral control of pain initiation. Prog Brain Res 129: 471-482

Calignano A, La Rana G, Makriyannis A, Lin SY, Beltramo M, Piomelli D (1997) Inhibition of intestinal motility by anandamide, an endogenous cannabinoid. Eur J Pharmacol 340: R7-8

Calignano A, La Rana G, Piomelli D (2001) Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. Eur J Pharmacol 419: 191-198

Campbell DS, Holt CE (2001) Chemotropic responses of retinal growth cones mediated by rapid local protein synthesis and degradation. Neuron 32: 1013-1026

Campbell DS, Regan AG, Lopez JS, Tannahill D, Harris WA, Holt CE (2001) Semaphorin 3A elicits stage-dependent collapse, turning, and branching in Xenopus retinal growth cones. J Neurosci 21: 8538-8547

Campbell VA (2001) Tetrahydrocannabinol-induced apoptosis of cultured cortical neurones is associated with cytochrome c release and caspase-3 activation. Neuropharmacology 40: 702-709

Cancela JM, Churchill GC, Galione A (1999) Coordination of agonist-induced Ca2+-signalling patterns by NAADP in pancreatic acinar cells. Nature 398: 74-76

Carayon P, Marchand J, Dussossoy D, Derocq JM, Jbilo O, Bord A, Bouaboula M, Galiegue S, Mondiere P, Penarier G, Fur GL, Defrance T, Casellas P (1998) Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation. Blood 92: 3605-3615

Cardy TJ, Taylor CW (1998) A novel role for calmodulin: Ca2+-independent inhibition of type-1 inositol trisphosphate receptors. Biochem J 334 (Pt 2): 447-455

Cardy TJ, Traynor D, Taylor CW (1997) Differential regulation of types-1 and -3 inositol trisphosphate receptors by cytosolic Ca2+. Biochem J 328 (Pt 3): 785-793

Carley DW, Paviovic S, Janelidze M, Radulovacki M (2002) Functional role for cannabinoids in respiratory stability during sleep. Sleep 25: 391-398

Carlisle SJ, Marciano-Cabral F, Staab A, Ludwick C, Cabral GA (2002) Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation. Int Immunopharmacol 2: 69-82

Carlson G, Wang Y, Alger BE (2002) Endocannabinoids facilitate the induction of LTP in the hippocampus. Nat Neurosci 5: 723-724

Carpenter CL, Cantley LC (1996) Phosphoinositide kinases. Curr Opin Cell Biol 8: 153-158

Carrier EJ, Kearn CS, Barkmeier AJ, Breese NM, Yang W, Nithipatikom K, Pfister SL, Campbell WB, Hillard CJ (2004) Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. Mol Pharmacol 65: 999-1007

Carriero D, Aberman J, Lin SY, Hill A, Makriyannis A, Salamone JD (1998) A detailed characterization of the effects of four cannabinoid agonists on operant lever pressing. Psychopharmacology (Berl) 137: 147-156

Carruthers AM, Sellers LA, Jenkins DW, Jarvie EM, Feniuk W, Humphrey PP (2001) Adenosine A(1) receptor-mediated inhibition of protein kinase A-induced calcitonin gene-related peptide release from rat trigeminal neurons. Mol Pharmacol 59: 1533-1541

Cartoni A, Margonelli A, Angelini G, Finazzi-Agro A, Maccarrone M (2004) Simplified chemical and radiochemical synthesis of 2-arachidonoyl-glycerol, an endogenous ligand of cannabinoid receptors. Tetrahedron Letters 45: 2723-2726

Castane A, Valjent E, Ledent C, Parmentier M, Maldonado R, Valverde O (2002) Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence. Neuropharmacology 43: 857-867

Castellano C, Cabib S, Palmisano A, Di Marzo V, Puglisi-Allegra S (1997) The effects of anandamide on memory consolidation in mice involve both D1 and D2 dopamine receptors. Behav Pharmacol 8: 707-712

Castellano C, Rossi-Arnaud C, Cestari V, Costanzi M (2003) Cannabinoids and memory: animal studies. Curr Drug Target CNS Neurol Disord 2: 389-402

Castellano C, Ventura R, Cabib S, Puglisi-Allegra S (1999) Strain-dependent effects of anandamide on memory consolidation in mice are antagonized by naltrexone. Behav Pharmacol 10: 453-457

Castillo PE, Chevaleyre V (2003) The time course of endocannabinoid - mediated depression of GABA release depends on the duration of CB1R activation. Society for Neuroscience Abstract Viewer and Itinerary Planner 2003

Casu MA, Porcella A, Ruiu S, Saba P, Marchese G, Carai MA, Reali R, Gessa GL, Pani L (2003) Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract. Eur J Pharmacol 459: 97-105

Catalano RD, Kyriakou T, Chen J, Easton A, Hillhouse EW (2003) Regulation of corticotropin-releasing hormone type 2 receptors by multiple promoters and alternative splicing: identification of multiple splice variants. Mol Endocrinol 17: 395-410

Cayre M, Buckingham SD, Yagodin S, Sattelle DB (1999) Cultured insect mushroom body neurons express functional receptors for acetylcholine, GABA, glutamate, octopamine, and dopamine. J Neurophysiol 81: 1-14

Centonze D, Battista N, Rossi S, Mercuri NB, Finazzi-Agro A, Bernardi G, Calabresi P, Maccarrone M (2004) A Critical Interaction between Dopamine D2 Receptors and Endocannabinoids Mediates the Effects of Cocaine on Striatal GABAergic Transmission. Neuropsychopharmacology

Cernak I, Vink R, Natale J, Stoica B, Lea PMt, Movsesyan V, Ahmed F, Knoblach SM, Fricke ST, Faden AI (2004) The "Dark Side" of Endocannabinoids: A Neurotoxic Role for Anandamide. J Cereb Blood Flow Metab 24: 564-578

Cesa R, Guastalla A, Cottone E, Mackie K, Beltramo M, Franzoni MF (2002) Relationships between CB1 cannabinoid receptors and pituitary endocrine cells in Xenopus laevis: an immunohistochemical study. Gen Comp Endocrinol 125: 17-24

Cesa R, Mackie K, Beltramo M, Franzoni MF (2001) Cannabinoid receptor CB1-like and glutamic acid decarboxylase-like immunoreactivities in the brain of Xenopus laevis. Cell Tissue Res 306: 391-398

Chadwick MP, Morling FJ, Cosset FL, Russell SJ (1999) Modification of retroviral tropism by display of IGF-I. J Mol Biol 285: 485-494

Chakrabarti A, Ekuta JE, Onaivi ES (1998) Neurobehavioral effects of anandamide and cannabinoid receptor gene expression in mice. Brain Res Bull 45: 67-74

Chakrabarti A, Onaivi ES, Chaudhuri G (1995) Cloning and sequencing of a cDNA encoding the mouse brain-type cannabinoid receptor protein. DNA Seq 5: 385-388

Challis BG, Pritchard LE, Creemers JW, Delplanque J, Keogh JM, Luan J, Wareham NJ, Yeo GS, Bhattacharyya S, Froguel P, White A, Farooqi IS, O'Rahilly S (2002) A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Hum Mol Genet 11: 1997-2004

Chalmers CJ, Balmanno K, Hadfield K, Ley R, Cook SJ (2003) Thrombin inhibits Bim (Bcl-2-interacting mediator of cell death) expression and prevents serum-withdrawal-induced apoptosis via protease-activated receptor 1. Biochem J 375: 99-109

Chan HC, Kuo SC, Liu SC, Liu CH, Hsu SL (2002) 4-Fluoro-N-butylphenylacetamide: a synthetic phenylacetate derivative that upregulates Bcl-X(S), activates caspase cascade and induces apoptosis in human squamous lung cancer CH27 cells. Cancer Lett 186: 211-221

Chan PK, Yung WH (1998) Occlusion of the presynaptic action of cannabinoids in rat substantia nigra pars reticulata by cadmium. Neurosci Lett 249: 57-60

Chang SI, Hammes GG (1988) Amino acid sequences of substrate-binding sites in chicken liver fatty acid synthase. Biochemistry 27: 4753-4760

Chang YH, Lee ST, Lin WW (2001) Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids. J Cell Biochem 81: 715-723

Changya L, Gallacher DV, Irvine RF, Petersen OH (1989) Inositol 1,3,4,5-tetrakisphosphate and inositol 1,4,5-trisphosphate act by different mechanisms when controlling Ca2+ in mouse lacrimal acinar cells. FEBS Lett 251: 43-48

Changya L, Gallacher DV, Irvine RF, Potter BV, Petersen OH (1989) Inositol 1,3,4,5-tetrakisphosphate is essential for sustained activation of the Ca2+-dependent K+ current in single internally perfused mouse lacrimal acinar cells. J Membr Biol 109: 85-93

Chaperon F, Soubrie P, Puech AJ, Thiebot MH (1998) Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats. Psychopharmacology (Berl) 135: 324-332

Chaperon F, Thiebot MH (1999) Behavioral effects of cannabinoid agents in animals. Crit Rev Neurobiol 13: 243-281

Chapman KD (1998) Phospholipase acitivity in plant growth and development and in response to environmental stress. Trends in Plant Science 3: 319-426

Chapman KD (2000) Emerging physiological roles for N-acylphosphatidylethanolamine metabolism in plants: signal transduction and membrane protection. Chem Phys Lipids 108: 221-229

Chapman KD (2004) Occurrence, metabolism, and prospective functions of N-acylethanolamines in plants. Prog Lipid Res 43: 302-327

Chapman KD, Lin I, DeSouza AD (1995) Metabolism of cottonseed microsomal N-acylphosphatidylethanolamine. Arch Biochem Biophys 318: 401-407

Chapman KD, Moore TS, Jr. (1993) N-acylphosphatidylethanolamine synthesis in plants: occurrence, molecular composition, and phospholipid origin. Arch Biochem Biophys 301: 21-33

Chapman KD, Sprinkle WB (1996) Developmental, tissue-specific, and environmental factors regulate the biosynthesis of N-acylphosphatidyl-ethanolamine in cotton (Gossypium hirsutum L.). Journal of Plant Physiology 149: 277-284

Chapman KD, Tripathy S, Venables B, Desouza AD (1998) N-Acylethanolamines: formation and molecular composition of a new class of plant lipids. Plant Physiol 116: 1163-1168

Chapman KD, Venables B, Markovic R, Blair RW, Jr., Bettinger C (1999) N-Acylethanolamines in seeds. Quantification of molecular species and their degradation upon imbibition. Plant Physiology (Rockville) 120: 1157-1164

Chapman KD, Venables BJ, Dian EE, Grossa GW (2003) Identification and quantification of neuroactive N-acylethanolamines in cottonseed processing fractions. Journal of the American Oil Chemists Society 80: 223-229

Chapman V (1999) The cannabinoid CB1 receptor antagonist, SR141716A, selectively facilitates nociceptive responses of dorsal horn neurones in the rat. Br J Pharmacol 127: 1765-1767

Charnock-Jones DS, Burton GJ (2000) Placental vascular morphogenesis. Baillieres Best Pract Res Clin Obstet Gynaecol 14: 953-968

Charnock-Jones DS, Clark DE, Licence D, Day K, Wooding FB, Smith SK (2001) Distribution of vascular endothelial growth factor (VEGF) and its binding sites at the maternal-fetal interface during gestation in pigs. Reproduction 122: 753-760

Chataigneau T, Feletou M, Thollon C, Villeneuve N, Vilaine JP, Duhault J, Vanhoutte PM (1998) Cannabinoid CB1 receptor and endothelium-dependent hyperpolarization in guinea-pig carotid, rat mesenteric and porcine coronary arteries. Br J Pharmacol 123: 968-974

Chatterjee VK (2001) Resistance to thyroid hormone, and peroxisome-proliferator-activated receptor gamma resistance. Biochem Soc Trans 29: 227-231

Chatwin HM, Rudling JE, Patel D, Reale V, Evans PD (2003) Site-directed mutagenesis studies on the Drosophila octopamine/tyramine receptor. Insect Biochem Mol Biol 33: 173-184

Chau PL, Howe PW (2002) Analysis methods for identifying coordinated movements during ligand unbinding. J Comput Aided Mol Des 16: 755-765

Chawla S, Huang CL (2004) FPL-64176 alters both charge movement and Ca(2+) release properties in amphibian muscle fibres. Pflugers Arch

Chawla S, Skepper JN, Hockaday AR, Huang CL (2001) Calcium waves induced by hypertonic solutions in intact frog skeletal muscle fibres. J Physiol 536: 351-359

Chawla S, Skepper JN, Huang CL (2002) Differential effects of sarcoplasmic reticular Ca(2+)-ATPase inhibition on charge movements and calcium transients in intact amphibian skeletal muscle fibres. J Physiol 539: 869-882

Chaytor AT, Martin PE, Evans WH, Randall MD, Griffith TM (1999) The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication. J Physiol 520 Pt 2: 539-550

Cheer JF, Cadogan AK, Marsden CA, Fone KC, Kendall DA (1999) Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors. Neuropharmacology 38: 533-541

Cheer JF, Kendall DA, Marsden CA (1998) In vivo evidence for oleamide as a potential endocannabinoid ligand. British Journal of Pharmacology 125

Cheer JF, Marsden CA, Kendall DA, Mason R (2000) Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study. Neuroscience 99: 661-667

Cheer JF, Wassum KM, Heien ML, Phillips PE, Wightman RM (2004) Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats. J Neurosci 24: 4393-4400

Chemin J, Monteil A, Perez-Reyes E, Nargeot J, Lory P (2001) Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. Embo J 20: 7033-7040

Chemin J, Nargeot J, Lory P (2002) Neuronal T-type alpha 1H calcium channels induce neuritogenesis and expression of high-voltage-activated calcium channels in the NG108-15 cell line. J Neurosci 22: 6856-6862

Chen K, Ratzliff A, Hilgenberg L, Gulyas A, Freund TF, Smith M, Dinh TP, Piomelli D, Mackie K, Soltesz I (2003) Long-term plasticity of endocannabinoid signaling induced by developmental febrile seizures. Neuron 39: 599-611

Chen N, Appell M, Berfield JL, Reith ME (2003) Inhibition by arachidonic acid and other fatty acids of dopamine uptake at the human dopamine transporter. Eur J Pharmacol 478: 89-95

Chen RZ, Huang RR, Shen CP, MacNeil DJ, Fong TM (2004) Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice. Brain Res 999: 227-230

Chen WC, Huang JK, Cheng JS, Tsai JC, Chiang AJ, Chou KJ, Liu CP, Jan CR (2001) AM-404 elevates renal intracellular Ca(2+), questioning its selectivity as a pharmacological tool for investigating the anandamide transporter. J Pharmacol Toxicol Methods 45: 195-198

Chen Y, McCarron RM, Ohara Y, Bembry J, Azzam N, Lenz FA, Shohami E, Mechoulam R, Spatz M (2000) Human brain capillary endothelium: 2-arachidonoglycerol (endocannabinoid) interacts with endothelin-1. Circ Res 87: 323-327

Cheng H, Straub SG, Sharp GW (2003) Protein acylation in the inhibition of insulin secretion by norepinephrine, somatostatin, galanin, and PGE2. Am J Physiol Endocrinol Metab 285: E287-294

Chevaleyre V, Castillo PE (2003) Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron 38: 461-472

Chevaleyre V, Castillo PE (2003) Synaptic specificity of endocannabinoid - mediated LTD at hippocampal inhibitory synapses. Society for Neuroscience Abstract Viewer and Itinerary Planner 2003

Child CJ, Shoolingin-Jordan PM (1998) Inactivation of the polyketide synthase, 6-methylsalicylic acid synthase, by the specific modification of Cys-204 of the beta-ketoacyl synthase by the fungal mycotoxin cerulenin. Biochem J 330 (Pt 2): 933-937

Child CJ, Spencer JB, Bhogal P, Shoolingin-Jordan PM (1996) Structural similarities between 6-methylsalicylic acid synthase from Penicillium patulum and vertebrate type I fatty acid synthase: evidence from thiol modification studies. Biochemistry 35: 12267-12274

Childers SR, Breivogel CS (1998) Cannabis and endogenous cannabinoid systems. Drug Alcohol Depend 51: 173-187

Childers SR, Deadwyler SA (1996) Role of cyclic AMP in the actions of cannabinoid receptors. Biochem Pharmacol 52: 819-827

Childers SR, Sexton T, Roy MB (1994) Effects of anandamide on cannabinoid receptors in rat brain membranes. Biochem Pharmacol 47: 711-715

Chin CN, Lucas-Lenard J, Abadji V, Kendall DA (1998) Ligand binding and modulation of cyclic AMP levels depend on the chemical nature of residue 192 of the human cannabinoid receptor 1. J Neurochem 70: 366-373

Chin CN, Murphy JW, Huffman JW, Kendall DA (1999) The third transmembrane helix of the cannabinoid receptor plays a role in the selectivity of aminoalkylindoles for CB2, peripheral cannabinoid receptor. J Pharmacol Exp Ther 291: 837-844

Choi G, Landin J, Xie XQ (2002) The cytoplasmic helix of cannabinoid receptor CB2, a conformational study by circular dichroism and (1)H NMR spectroscopy in aqueous and membrane-like environments. J Pept Res 60: 169-177

Chou KJ, Tseng LL, Cheng JS, Wang JL, Fang HC, Lee KC, Su W, Law YP, Jan CR (2001) CP55,940 increases intracellular Ca2+ levels in Madin-Darby canine kidney cells. Life Sci 69: 1541-1548

Christopoulos A, Coles P, Lay L, Lew MJ, Angus JA (2001) Pharmacological analysis of cannabinoid receptor activity in the rat vas deferens. Br J Pharmacol 132: 1281-1291

Christopoulos A, Wilson K (2001) Interaction of anandamide with the M(1) and M(4) muscarinic acetylcholine receptors. Brain Res 915: 70-78

Chu C, Ramamurthy A, Makriyannis A, Tius MA (2003) Synthesis of covalent probes for the radiolabeling of the cannabinoid receptor. J Org Chem 68: 55-61

Chu CJ, Huang SM, De Petrocellis L, Bisogno T, Ewing SA, Miller JD, Zipkin RE, Daddario N, Appendino G, Di Marzo V, Walker JM (2003) N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia. J Biol Chem 278: 13633-13639

Chuang SC, Bianchi R, Wong RK (2000) Group I mGluR activation turns on a voltage-gated inward current in hippocampal pyramidal cells. J Neurophysiol 83: 2844-2853

Chuchawankul S, Shima M, Buckley NE, Hartmann CB, McCoy KL (2004) Role of cannabinoid receptors in inhibiting macrophage costimulatory activity. Int Immunopharmacol 4: 265-278

Chudasama Y, Dalley JW, Nathwani F, Bouger P, Robbins TW (2004) Cholinergic modulation of visual attention and working memory: dissociable effects of basal forebrain 192-IgG-saporin lesions and intraprefrontal infusions of scopolamine. Learn Mem 11: 78-86

Ciccolini F (2001) Identification of two distinct types of multipotent neural precursors that appear sequentially during CNS development. Mol Cell Neurosci 17: 895-907

Ciccolini F, Collins TJ, Sudhoelter J, Lipp P, Berridge MJ, Bootman MD (2003) Local and global spontaneous calcium events regulate neurite outgrowth and onset of GABAergic phenotype during neural precursor differentiation. J Neurosci 23: 103-111

Cichewicz DL, Haller VL, Welch SP (2001) Changes in opioid and cannabinoid receptor protein following short-term combination treatment with delta(9)-tetrahydrocannabinol and morphine. J Pharmacol Exp Ther 297: 121-127

Cipolla C, Occhionero T, Orciari P, Lugo G, D'Antuono G (1990) Magnesium pidolate in the treatment of seasonal allergic rhinitis. Preliminary data. Magnes Res 3: 109-112

Clark DE, Smith SK, He Y, Day KA, Licence DR, Corps AN, Lammoglia R, Charnock-Jones DS (1998) A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod 59: 1540-1548

Clark DE, Smith SK, Sharkey AM, Charnock-Jones DS (1996) Localization of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy. Hum Reprod 11: 1090-1098

Clark K, Hammond E, Rabbitts P (2002) Temporal and spatial expression of two isoforms of the Dutt1/Robo1 gene in mouse development. FEBS Lett 523: 12-16

Clatworthy MR, Smith KG (2004) Fc{gamma}RIIb Balances Efficient Pathogen Clearance and the Cytokine-mediated Consequences of Sepsis. J Exp Med 199: 717-723

Clayton E, Bardi G, Bell SE, Chantry D, Downes CP, Gray A, Humphries LA, Rawlings D, Reynolds H, Vigorito E, Turner M (2002) A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation. J Exp Med 196: 753-763

Clayton GM, Peak-Chew SY, Evans RM, Schwabe JW (2001) The structure of the ultraspiracle ligand-binding domain reveals a nuclear receptor locked in an inactive conformation. Proc Natl Acad Sci U S A 98: 1549-1554

Clayton N, Marshall FH, Bountra C, O'Shaughnessy CT (2002) CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain. Pain 96: 253-260

Clement AB, Hawkins EG, Lichtman AH, Cravatt BF (2003) Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase. J Neurosci 23: 3916-3923

Coates JC, de Bono M (2002) Antagonistic pathways in neurons exposed to body fluid regulate social feeding in Caenorhabditis elegans. Nature 419: 925-929

Coburn AF, Graham CE, Haninger J (1954) The effect of egg yolk in diets on anaphylactic arthritis (passive Arthus phenomenon) in the guinea pig. J Exp Med 100: 425-435

Coco S, Calegari F, Pravettoni E, Pozzi D, Taverna E, Rosa P, Matteoli M, Verderio C (2003) Storage and release of ATP from astrocytes in culture. J Biol Chem 278: 1354-1362

Coffey RG, Yamamoto Y, Snella E, Pross S (1996) Tetrahydrocannabinol inhibition of macrophage nitric oxide production. Biochem Pharmacol 52: 743-751

Cole SL, Schindler M, Sellers LA, Humphrey PP (2001) Titrating the expression of a Gi protein-coupled receptor using an ecdysone-inducible system in CHO-K1 cells. Receptors Channels 7: 289-302

Colgin LL, Kramar EA, Gall CM, Lynch G (2003) Septal modulation of excitatory transmission in hippocampus. J Neurophysiol 90: 2358-2366

Collier S, Chan HY, Toda T, McKimmie C, Johnson G, Adler PN, O'Kane C, Ashburner M (2000) The Drosophila embargoed gene is required for larval progression and encodes the functional homolog of schizosaccharomyces Crm1. Genetics 155: 1799-1807

Collin C, Devane WA, Dahl D, Lee CJ, Axelrod J, Alkon DL (1995) Long-term synaptic transformation of hippocampal CA1 gamma-aminobutyric acid synapses and the effect of anandamide. Proc Natl Acad Sci U S A 92: 10167-10171

Collingwood TN, Butler A, Tone Y, Clifton-Bligh RJ, Parker MG, Chatterjee VK (1997) Thyroid hormone-mediated enhancement of heterodimer formation between thyroid hormone receptor beta and retinoid X receptor. J Biol Chem 272: 13060-13065

Collingwood TN, Wagner R, Matthews CH, Clifton-Bligh RJ, Gurnell M, Rajanayagam O, Agostini M, Fletterick RJ, Beck-Peccoz P, Reinhardt W, Binder G, Ranke MB, Hermus A, Hesch RD, Lazarus J, Newrick P, Parfitt V, Raggatt P, de Zegher F, Chatterjee VK (1998) A role for helix 3 of the TRbeta ligand-binding domain in coactivator recruitment identified by characterization of a third cluster of mutations in resistance to thyroid hormone. Embo J 17: 4760-4770

Colognato H, Baron W, Avellana-Adalid V, Relvas JB, Baron-Van Evercooren A, Georges-Labouesse E, ffrench-Constant C (2002) CNS integrins switch growth factor signalling to promote target-dependent survival. Nat Cell Biol 4: 833-841

Colombo G, Agabio R, Diaz G, Lobina C, Reali R, Gessa GL (1998) Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci 63: PL113-117

Colombo G, Agabio R, Fa M, Guano L, Lobina C, Loche A, Reali R, Gessa GL (1998) Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716. Alcohol Alcohol 33: 126-130

Colombo G, Agabio R, Lobina C, Reali R, Gessa GL (1998) Cannabinoid modulation of intestinal propulsion in mice. Eur J Pharmacol 344: 67-69

Colombo G, Serra S, Brunetti G, Gomez R, Melis S, Vacca G, Carai MM, Gessa L (2002) Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats. Psychopharmacology (Berl) 159: 181-187

Comings DE, Muhleman D, Gade R, Johnson P, Verde R, Saucier G, MacMurray J (1997) Cannabinoid receptor gene (CNR1): association with i.v. drug use. Mol Psychiatry 2: 161-168

Compston J (2000) Prevention of osteoporotic fractures in post-menopausal women. Baillieres Best Pract Res Clin Endocrinol Metab 14: 251-264

Compton DR, Martin BR (1997) The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity. J Pharmacol Exp Ther 283: 1138-1143

Condie R, Herring A, Koh WS, Lee M, Kaminski NE (1996) Cannabinoid inhibition of adenylate cyclase-mediated signal transduction and interleukin 2 (IL-2) expression in the murine T-cell line, EL4.IL-2. J Biol Chem 271: 13175-13183

Consroe P (1998) Brain cannabinoid systems as targets for the therapy of neurological disorders. Neurobiol Dis 5: 534-551

Contassot E, Tenan M, Schnuriger V, Pelte MF, Dietrich PY (2004) Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1. Gynecol Oncol 93: 182-188

Conti S, Costa B, Colleoni M, Parolaro D, Giagnoni G (2002) Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat. Br J Pharmacol 135: 181-187

Contreras CM, Gutierrez-Garcia AG, Saavedra M, Bernal-Morales B, Rodriguez-Landa JF, Hernandez-Lozano M (2003) Adverse and palliative effects of the cannabinoids. Salud Mental 26: 62-75

Cook JL, Giardina JF, Zhang Z, Re RN (2002) Intracellular angiotensin II increases the long isoform of PDGF mRNA in rat hepatoma cells. J Mol Cell Cardiol 34: 1525-1537

Cook LJ, Ho LW, Taylor AE, Brayne C, Evans JG, Xuereb J, Cairns NJ, Pritchard A, Lemmon H, Mann D, St Clair D, Turic D, Hollingworth P, Moore PJ, Jehu L, Archer N, Walter S, Foy C, Edmondson A, Powell J, Lovestone S, Owen MJ, Williams J, Lendon C, Rubinsztein DC (2004) Candidate gene association studies of the alpha4 (CHRNA4) and beta2 (CHRNB2) neuronal nicotinic acetylcholine receptor subunit genes in Alzheimer's disease. Neurosci Lett 358: 142-146

Cook SA, Lowe JA, Martin BR (1998) CB1 receptor antagonist precipitates withdrawal in mice exposed to Delta9-tetrahydrocannabinol. J Pharmacol Exp Ther 285: 1150-1156

Cooper I, Lord T, Tice PA (1995) Hydrolysis studies on oleamide in simulated gastrointestinal fluids. Food Addit Contam 12: 769-777

Cooper MA (2003) Biosensor profiling of molecular interactions in pharmacology. Curr Opin Pharmacol 3: 557-562

Cooper MA (2003) Label-free screening of bio-molecular interactions. Anal Bioanal Chem 377: 834-842

Cooper MA, Hansson A, Lofas S, Williams DH (2000) A vesicle capture sensor chip for kinetic analysis of interactions with membrane-bound receptors. Anal Biochem 277: 196-205

Cooper MT, Bray SJ (2000) R7 photoreceptor specification requires Notch activity. Curr Biol 10: 1507-1510

Copello JA, Qi Y, Jeyakumar LH, Ogunbunmi E, Fleischer S (2001) Lack of effect of cADP-ribose and NAADP on the activity of skeletal muscle and heart ryanodine receptors. Cell Calcium 30: 269-284

Corchero J, Romero J, Berrendero F, Fernandez-Ruiz J, Ramos JA, Fuentes JA, Manzanares J (1999) Time-dependent differences of repeated administration with Delta9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by mu-opioid and CB1-cannabinoid receptors in the caudate-putamen. Brain Res Mol Brain Res 67: 148-157

Correa V, Riley AM, Shuto S, Horne G, Nerou EP, Marwood RD, Potter BV, Taylor CW (2001) Structural determinants of adenophostin A activity at inositol trisphosphate receptors. Mol Pharmacol 59: 1206-1215

Corti C, Clarkson RW, Crepaldi L, Sala CF, Xuereb JH, Ferraguti F (2003) Gene structure of the human metabotropic glutamate receptor 5 and functional analysis of its multiple promoters in neuroblastoma and astroglioma cells. J Biol Chem 278: 33105-33119

Corti C, Xuereb JH, Corsi M, Ferraguti F (2001) Identification and characterization of the promoter region of the GRM3 gene. Biochem Biophys Res Commun 286: 381-387

Coruzzi G, Adami M, Coppelli G, Frati P, Soldani G (1999) Inhibitory effect of the cannabinoid receptor agonist WIN 55,212-2 on pentagastrin-induced gastric acid secretion in the anaesthetized rat. Naunyn Schmiedebergs Arch Pharmacol 360: 715-718

Cosenza M, Gifford AN, Gatley SJ, Pyatt B, Liu Q, Makriyannis A, Volkow ND (2000) Locomotor activity and occupancy of brain cannabinoid CB1 receptors by the antagonist/inverse agonist AM281. Synapse 38: 477-482

Cossu G, Ledent C, Fattore L, Imperato A, Bohme GA, Parmentier M, Fratta W (2001) Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav Brain Res 118: 61-65

Costa B, Colleoni M (1999) SR141716A induces in rats a behavioral pattern opposite to that of CB1 receptor agonists. Zhongguo Yao Li Xue Bao 20: 1103-1108

Costa B, Colleoni M (2000) Changes in rat brain energetic metabolism after exposure to anandamide or Delta(9)-tetrahydrocannabinol. Eur J Pharmacol 395: 1-7

Costa B, Giagnoni G, Colleoni M (2000) Precipitated and spontaneous withdrawal in rats tolerant to anandamide. Psychopharmacology (Berl) 149: 121-128

Costa B, Parolaro D, Colleoni M (2002) Chronic treatment with the endocannabinoid anandamide increases cytochrome P450 metabolizing system in the rat. Eur J Pharmacol 449: 61-69

Costa B, Vailati S, Colleoni M (1999) SR 141716A, a cannabinoid receptor antagonist, reverses the behavioural effects of anandamide-treated rats. Behav Pharmacol 10: 327-331

Costanzi M, Battaglia M, Populin R, Cestari V, Castellano C (2003) Anandamide and memory in CD1 mice: effects of immobilization stress and of prior experience. Neurobiol Learn Mem 79: 204-211

Costanzi M, Battaglia M, Rossi-Arnaud C, Cestari V, Castellano C (2004) Effects of anandamide and morphine combinations on memory consolidation in cd1 mice: involvement of dopaminergic mechanisms. Neurobiol Learn Mem 81: 144-149

Costentin J (2000) [Pain and its main transmitters]. Ann Pharm Fr 58: 77-83

Cota D, Genghini S, Pasquali R, Pagotto U (2003) Antagonizing the cannabinoid receptor Type 1: A dual way to fight obesity. Journal of Endocrinological Investigation 26: 1041-1044

Cota D, Marsicano G, Lutz B, Vicennati V, Stalla GK, Pasquali R, Pagotto U (2003) Endogenous cannabinoid system as a modulator of food intake. Int J Obes Relat Metab Disord 27: 289-301

Cota D, Marsicano G, Tschop M, Grubler Y, Flachskamm C, Schubert M, Auer D, Yassouridis A, Thone-Reineke C, Ortmann S, Tomassoni F, Cervino C, Nisoli E, Linthorst AC, Pasquali R, Lutz B, Stalla GK, Pagotto U (2003) The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112: 423-431

Cotterill LA, Gower JD, Fuller BJ, Green CJ (1990) Evidence that calcium mediates free radical damage through activation of phospholipase A2 during cold storage of the rabbit kidney. Adv Exp Med Biol 264: 397-400

Cottone E, Salio C, Conrath M, Franzoni MF (2003) Xenopus laevis CB1 cannabinoid receptor: molecular cloning and mRNA distribution in the central nervous system. J Comp Neurol 464: 487-496

Cousins GR, Furlan RL, Ng YF, Redman JE, Sanders JK (2001) Identification and Isolation of a Receptor for N-Methyl Alkylammonium Salts: Molecular Amplification in a Pseudo-peptide Dynamic Combinatorial Library This work was supported by the Biotechnology and Biological Sciences Research Council (UK), Engineering and Physical Sciences Research Council (UK), Ethyl Corporation (UK), and Fundacion Antorchas and Consejo Nacional de Investigaciones Cientficas y Tecnicas (Argentina). Angew Chem Int Ed Engl 40: 423-428

Cousins GR, Poulsen SA, Sanders JK (2000) Molecular evolution: dynamic combinatorial libraries, autocatalytic networks and the quest for molecular function. Curr Opin Chem Biol 4: 270-279

Coutts AA, Anavi-Goffer S, Ross RA, MacEwan DJ, Mackie K, Pertwee RG, Irving AJ (2001) Agonist-induced internalization and trafficking of cannabinoid CB1 receptors in hippocampal neurons. J Neurosci 21: 2425-2433

Coutts AA, Brewster N, Ingram T, Razdan RK, Pertwee RG (2000) Comparison of novel cannabinoid partial agonists and SR141716A in the guinea-pig small intestine. Br J Pharmacol 129: 645-652

Coutts AA, Irving AJ, Mackie K, Pertwee RG, Anavi-Goffer S (2002) Localisation of cannabinoid CB(1) receptor immunoreactivity in the guinea pig and rat myenteric plexus. J Comp Neurol 448: 410-422

Coutts AA, Pertwee RG (1997) Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus. Br J Pharmacol 121: 1557-1566

Coutts AA, Pertwee RG (1998) Evidence that cannabinoid-induced inhibition of electrically evoked contractions of the myenteric plexus--longitudinal muscle preparation of guinea-pig small intestine can be modulated by Ca2+ and cAMP. Can J Physiol Pharmacol 76: 340-346

Craib SJ, Ellington HC, Pertwee RG, Ross RA (2001) A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus. Br J Pharmacol 134: 30-37

Cranston AN, Ponder BA (2003) Modulation of medullary thyroid carcinoma penetrance suggests the presence of modifier genes in a RET transgenic mouse model. Cancer Res 63: 4777-4780

Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR, Lichtman AH (2001) Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci U S A 98: 9371-9376

Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384: 83-87

Cravatt BF, Lichtman AH (2002) The enzymatic inactivation of the fatty acid amide class of signaling lipids. Chem Phys Lipids 121: 135-148

Cravatt BF, Lichtman AH (2003) Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. Curr Opin Chem Biol 7: 469-475

Crawford JH, Wainwright A, Heavens R, Pollock J, Martin DJ, Scott RH, Seabrook GR (2000) Mobilisation of intracellular Ca2+ by mGluR5 metabotropic glutamate receptor activation in neonatal rat cultured dorsal root ganglia neurones. Neuropharmacology 39: 621-630

Crawley JN, Corwin RL, Robinson JK, Felder CC, Devane WA, Axelrod J (1993) Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. Pharmacol Biochem Behav 46: 967-972

Crease DJ, Dyson S, Gurdon JB (1998) Cooperation between the activin and Wnt pathways in the spatial control of organizer gene expression. Proc Natl Acad Sci U S A 95: 4398-4403

Creedon DJ, Johnson EM, Lawrence JC (1996) Mitogen-activated protein kinase-independent pathways mediate the effects of nerve growth factor and cAMP on neuronal survival. J Biol Chem 271: 20713-20718

Croci T, Landi M, Galzin AM, Marini P (2003) Role of cannabinoid CB1 receptors and tumor necrosis factor-alpha in the gut and systemic anti-inflammatory activity of SR 141716 (Rimonabant) in rodents. Br J Pharmacol 140: 115-122

Croci T, Manara L, Aureggi G, Guagnini F, Rinaldi-Carmona M, Maffrand JP, Le Fur G, Mukenge S, Ferla G (1998) In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum. Br J Pharmacol 125: 1393-1395

Crowley VE, Yeo GS, O'Rahilly S (2002) Obesity therapy: altering the energy intake-and-expenditure balance sheet. Nat Rev Drug Discov 1: 276-286

Croxford JL (2003) Therapeutic potential of cannabinoids in CNS disease. CNS Drugs 17: 179-202

Crozier Willi G, Berger A, Di Marzo V, Bisogno T, De Petrocellis L, Fride E, Mechoulam R (2001) Lipids in neural function: modulation of behavior by oral administration of endocannabinoids found in foods. Nestle Nutr Workshop Ser Clin Perform Programme: 169-184; discussion 185-167

Cruz F (2004) Mechanisms involved in new therapies for overactive bladder. Urology 63: 65-73

Cryan JF, Gasparini F, van Heeke G, Markou A (2003) Non-nicotinic neuropharmacological strategies for nicotine dependence: beyond bupropion. Drug Discov Today 8: 1025-1034